OncoTracking™ monitors for early signs
of cancer recurrence
Whether a patient is in remission or is currently undergoing treatment.
The sooner cancer recurrence or metastasis is found, the sooner the patient can receive appropriate therapy and treatment.
That’s why we’ve created OncoTracking™, a testing program that screens for unique tumor biomarkers in a patient’s blood and may detect signs of cancer recurrence earlier than traditional screening methods.